Pharmaceutical company Biofarm (BIO.RO) is to become subject to a voluntary tender offer (VTO) from Zakłady Farmaceutyczne Polpharma S.A, a Polish pharmaceutical producer. The announcement came from Longshield Investment Group S.A, which owns 51.6787% in Biofarm, on Wednesday, May 6, 2026.